Form 483

BioChroma Analytical Labs, LLC. Form 483, 2017-02-08

FDA issued a Form 483 to BioChroma Analytical Labs, LLC. on 2017-02-08 with 4 public-safe observations.

483· Form 483 issuedHuman Drugs4 observations

BioChroma Analytical Labs, LLC. · Dallas, United States · Issued February 8, 2017

Overview

  • 4 public-safe observations are available for this inspection.
  • 4 structured CFR citations are represented.
  • 1 investigator is tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

8 Feb 2017
21 CFR 211.160(b)(4)

Establishment of calibration procedures

Cited by Anh Lac

8 Feb 2017
21 CFR 211.165(e)

Test methods

Cited by Anh Lac

8 Feb 2017
21 CFR 211.68(a)

Calibration/Inspection/Checking not done

Cited by Anh Lac

8 Feb 2017
21 CFR 211.68(b)

Computer control of master formula records

Cited by Anh Lac

Inspected site

BABioChroma Analytical Labs, LLC.Dallas, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 211.160(b)(4)Cited across public-safe Form 483 observations1x
21 CFR 211.165(e)Cited across public-safe Form 483 observations1x
21 CFR 211.68(a)Cited across public-safe Form 483 observations1x
21 CFR 211.68(b)Cited across public-safe Form 483 observations1x

Full 483 report

Get the verbatim text of all 4 observations

Every observation in full, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere